BioCreative VI Precision Medicine Track system performance is constrained by entity recognition and variations in corpus characteristics

Abstract

Precision medicine aims to provide personalized treatments based on individual patient profiles. One critical step towards precision medicine is leveraging knowledge derived from biomedical publications-a tremendous literature resource presenting the latest scientific discoveries on genes, mutations and diseases. Biomedical natural language processing (BioNLP) plays a vital role in supporting automation of this process. BioCreative VI Track 4 brings community effort to the task of automatically identifying and extracting protein-protein interactions (PPi) affected by mutations (PPIm), important in the precision medicine context for capturing individual genotype variation related to disease.W..